| scholarly article | Q13442814 |
| P2093 | author name string | Cohen JI | |
| Armitage RJ | |||
| Spriggs MK | |||
| Farrah T | |||
| Lyman SD | |||
| DuBose RF | |||
| Strockbine LD | |||
| Wagener F | |||
| P2860 | cites work | A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types | Q24309431 |
| Biology and action of colony--stimulating factor-1 | Q24310399 | ||
| Molecular and biological characterization of human 4-1BB and its ligand | Q24320045 | ||
| Human macrophage-colony stimulating factor: alternative RNA and protein processing from a single gene | Q24338885 | ||
| Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34 | Q24568305 | ||
| Basic local alignment search tool | Q25938991 | ||
| A simple method for displaying the hydropathic character of a protein | Q26778481 | ||
| Molecular and biological characterization of a murine ligand for CD40 | Q28186605 | ||
| The immunoglobulin fold. Structural classification, sequence patterns and common core | Q28239187 | ||
| Interleukin-10 | Q28263225 | ||
| Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling | Q28272447 | ||
| Macrophage colony-stimulating factor is produced by human T lymphoblastoid cell line, CEM-ON: identification by amino-terminal amino acid sequence analysis | Q28294072 | ||
| Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein | Q28299182 | ||
| Ligands for the receptor tyrosine kinases hek and elk: isolation of cDNAs encoding a family of proteins | Q28306430 | ||
| Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion | Q31147001 | ||
| Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. | Q33189141 | ||
| A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes | Q33769954 | ||
| Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins | Q34181973 | ||
| Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor | Q34312346 | ||
| Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors | Q34441628 | ||
| cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily | Q34563479 | ||
| Structural analyses of the Epstein-Barr virus BamHI A transcripts | Q35832657 | ||
| The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame | Q35851440 | ||
| The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation | Q35866482 | ||
| The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines | Q35886322 | ||
| Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages | Q36180127 | ||
| Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death | Q36535182 | ||
| Identification of the ligand-binding regions in the macrophage colony-stimulating factor receptor extracellular domain | Q36698860 | ||
| Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo | Q36822172 | ||
| Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells | Q36868334 | ||
| Epstein-Barr virus transcription in nasopharyngeal carcinoma | Q36909993 | ||
| Colony-stimulating factor-1 receptor | Q37870336 | ||
| Transcriptional expression of Epstein-Barr virus genes and proto-oncogenes in north African nasopharyngeal carcinoma | Q39434417 | ||
| Interleukin-10 and its receptor | Q40429460 | ||
| A transforming function of the BARF1 gene encoded by Epstein-Barr virus | Q40819501 | ||
| One step ahead of the game: viral immunomodulatory molecules | Q41039669 | ||
| Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus | Q41103884 | ||
| Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders | Q41143497 | ||
| Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. | Q41476683 | ||
| Production of colony-stimulating factor 1 by T cells: possible involvement in their interaction with antigen-presenting cells | Q41545640 | ||
| CSF-I signal transduction: what is of functional significance? | Q41546313 | ||
| Both granulocyte-macrophage colony-stimulating factor and monocytic colony-stimulating factor are produced by the human T-cell line, HUT 102. | Q41716734 | ||
| Regulation of interleukin 4 receptors on human T cells | Q41774251 | ||
| Vaccinia Virus B18R Gene Encodes a Type I Interferon-binding Protein That Blocks Interferon α Transmembrane Signaling | Q42679205 | ||
| A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential | Q42801154 | ||
| Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). | Q42808913 | ||
| Macrophage colony-stimulating factor (CSF-1) gene expression in human T-lymphocyte clones. | Q44223701 | ||
| Epstein-Barr virus BCRF1 gene product (viral interleukin 10) inhibits superoxide anion production by human monocytes | Q44236162 | ||
| Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection | Q45778467 | ||
| Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity | Q45785576 | ||
| Conserved linkage between the puffer fish (Fugu rubripes) and human genes for platelet-derived growth factor receptor and macrophage colony-stimulating factor receptor | Q48057316 | ||
| Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor. | Q48079752 | ||
| The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms | Q48284399 | ||
| The Immunoglobulin Fold | Q55932791 | ||
| Soluble forms of CD40 inhibit biologic responses of human B cells | Q67897905 | ||
| Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity | Q68974281 | ||
| Macrophage colony-stimulating factor (M-CSF) enhances complement component C3 production by human monocytes/macrophages | Q70668420 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 4015-4021 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor | |
| P478 | volume | 72 |
| Q33632095 | A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors |
| Q30326102 | A broad spectrum secreted chemokine binding protein encoded by a herpesvirus |
| Q34345591 | A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels |
| Q33932737 | Accessing complexity: the dynamics of virus-specific T cell responses. |
| Q27681995 | Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1 |
| Q34539785 | An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection |
| Q34656773 | An Epstein-Barr-related herpesvirus from marmoset lymphomas |
| Q77454770 | Anti-apoptotic strategies of lymphotropic viruses |
| Q40073024 | Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases |
| Q38133428 | BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator. |
| Q45419158 | Biochemical and functional characterization of Epstein-Barr virus-encoded BARF1 protein: interaction with human hTid1 protein facilitates its maturation and secretion |
| Q33653719 | CSF-1 receptor signaling in myeloid cells |
| Q39185606 | Cellular localization of BARF1 oncoprotein and its cell stimulating activity in human epithelial cell |
| Q39630573 | Cloning of the Epstein-Barr Virus-Related Rhesus Lymphocryptovirus as a Bacterial Artificial Chromosome: a Loss-of-Function Mutation of the rhBARF1 Immune Evasion Gene |
| Q34061960 | Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and Herpesvirus saimiri |
| Q24540310 | Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model |
| Q34173615 | Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma |
| Q59351570 | Contribution of the KSHV and EBV lytic cycles to tumourigenesis |
| Q47117102 | EBV and Apoptosis: The Viral Master Regulator of Cell Fate? |
| Q38912277 | EBV glycoproteins: where are we now? |
| Q51416588 | Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma. |
| Q33650107 | Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. |
| Q37696106 | Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells. |
| Q35077651 | Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytes |
| Q36670819 | Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? |
| Q35586343 | Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation |
| Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
| Q36526103 | Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells |
| Q39296826 | Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation. |
| Q37252852 | Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB. |
| Q27003183 | Epstein-barr virus sequence variation-biology and disease |
| Q38111863 | Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses |
| Q45483067 | Expression and analysis of the Epstein-Barr virus BARF1-encoded protein from a tetracycline-regulatable adenovirus system |
| Q40794736 | Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. |
| Q34273467 | Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation |
| Q40750248 | Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus |
| Q39551333 | Identification and initial characterization of the murine gammaherpesvirus 68 gene M3, encoding an abundantly secreted protein |
| Q37652046 | Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity |
| Q39224323 | Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion. |
| Q35017852 | Immunological aspects of Epstein-Barr virus infection |
| Q39589786 | Infection of primary human monocytes by Epstein-Barr virus |
| Q45734610 | Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein |
| Q34742561 | Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus |
| Q34895103 | Manipulation of immune responses by Epstein-Barr virus. |
| Q39059671 | Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures |
| Q61448443 | MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control |
| Q40570096 | Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein |
| Q27670894 | Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1 |
| Q40811105 | N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. |
| Q39588263 | Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. |
| Q35026045 | Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders |
| Q35079839 | Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice |
| Q33760249 | Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients |
| Q41136819 | Recent Advances on the Possible Neuroprotective Activities of Epstein-Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System |
| Q39068689 | Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor |
| Q39257792 | Secretion of Epstein-Barr virus-encoded BARF1 oncoprotein from latently infected B cells |
| Q36023207 | Sequence analysis of Epstein-Barr virus (EBV) early genes BARF1 and BHRF1 in NK/T cell lymphoma from Northern China |
| Q24522326 | Simian homologues of Epstein-Barr virus |
| Q54189929 | Soluble chemokine binding proteins are also encoded by herpesviruses. |
| Q54245037 | The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis. |
| Q64243341 | The Phylogeographic Diversity of EBV and Admixed Ancestry in the Americas⁻Another Model of Disrupted Human-Pathogen Co-Evolution |
| Q26767186 | The Role of Gammaherpesviruses in Cancer Pathogenesis |
| Q33711382 | The biology of Epstein-Barr virus: lessons learned from the virus and the host |
| Q38440804 | The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma |
| Q45359052 | Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies |
| Q28201716 | Viral mimicry of cytokines, chemokines and their receptors |
| Q34394771 | Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses |
| Q33668769 | Virus-encoded modulators of cytokines and growth factors |
Search more.